Form 424B4 Iambic Therapeutics,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20261015/A42L9G2GZM2RKZZ2222O2ZYPDPT9ZZ22N282
Filed on: October 15, 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iambic Therapeutics prices IPO at $16 per share on Nasdaq
- Omer Istanbul Dental Clinic Moves into One of Europe’s Largest Dental Complexes
- Sue Schuster Helps Small Businesses Unlock Growth Capital with an 95% Funding Success Rate once pre-approved
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
